SCHEMBL6450335

SCHEMBL6450335

CCc1nn(CC)cc1NC1CCNC(=O)CC1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4762000 0.82 ALDH1A1 (0.35)
SCHEMBL4552449 0.79 RAB9A (0.40)
SCHEMBL4555150 0.78 RAB9A (0.42)
SCHEMBL5185734 0.76 PDE7A (0.39)
SCHEMBL5176743 0.76 PDE4B (0.39)
SCHEMBL5963533 0.75 POLB (0.36) KHK
SCHEMBL4554789 0.68 ALDH1A1 (0.49)
SCHEMBL6437921 0.65 PDE4B (0.40)
SCHEMBL3422561 0.64 LMNA (0.38)
SCHEMBL6469770 0.63 KAT2B (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1539753-A2 PYRAZOLO(3,4-B)PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS GLAXO GROUP LIMITED (GB) 2005-06-15 EP claimed
WO-2004024728-A2 PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS GLAXO GROUP LIMITED (GB) 2004-03-25 WO claimed